Performance and safety evaluation of the BioBall® MaxiMotion® Cup System in clinical routine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039076

Enrollment

150

Registered

2026-01-29

Start date

2025-12-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1

Interventions

Group 1: Retrospective analysis of clinical performance and safety data for patients treated with BioBall MaxiMotion during the period from 01-Lan-2020 till 31-dec-2024 at Unfallkrankenhaus Berlin.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who have been treated with the BioBall MaxiMotion System in routine clinical practice between 2020 and 2024 can be selected for this retrospective observation. Before the patient is enrolled in this study, written informed consent including the data protection declaration must be signed by each patient

Exclusion criteria

Exclusion criteria: Since the observation is intended to reflect clinical routine, no further exclusion criteria are defined.

Design outcomes

Primary

Measure	Time frame
The aim of the measure is to demonstrate clinical performance and safety using retrospective data	—

Countries

Germany

Contacts

Public ContactNikolai Spranger

Unfallkrankenhaus Berlin, Klinik für Unfallchirurgie und Orthopädie

nikolai.spranger@ukb.de+49 (30) 56 81 - 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026